A lower risk for all-cause death was also observed in GLP-1 RAs users (with HF: HR 0.45
Similarly, Palathy et al
The questions are designed to identify patients who should not take tirzepatide, including those with a personal or family history of medullary thyroid carcinoma, a history of pancreatitis, or active gallbladder disease
Baca-Atlas emphasized that while the findings are promising, further research is necessary to understand the full potential of GLP-1 medications for addiction treatment
The most effective sites and usually recommended by your doctor, are the abdomen, thigh, upper arms, and buttocks
These compounds can interact with various receptors in the body, influencing biological processes such as metabolism, appetite, and fat breakdown